Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Roche Raises Bid for Illumina

By Pharmaceutical Processing | March 29, 2012

GENEVA (AP) — The Roche Group raised its offer for Illumina Inc. to $51 cash per share Thursday, in a bid to speed up a takeover of the U.S. diagnostics company.

The offer represents an increase of almost 15 percent on Roche’s previous offer of $44.50 per share that was unanimously rejected by Illumina’s board.

“Based on our discussions with Illumina shareholders we have seen interest to accelerate the takeover process,” said Roche CEO Severin Schwan in a statement.

But Illumina immediately cautioned its shareholders to wait before accepting the new offer, which values the San Diego-based DNA sequencing specialist at about $6.5 billion.

“Illumina’s board of directors will thoroughly review Roche’s revised proposal and make a recommendation to stockholders regarding the proposal in due course,” it said. The offer runs until April 20.

Analysts had expected Roche to increase its bid after Illumina’s share price rose to about $50 following the initial takeover offer.

“We see a win-win situation for both sides in a takeover,” Zuercher Kantonalbank said in an analyst note.

Roche shares were down 1.1 percent at 158.10 Swiss francs ($174.93) on the Zurich exchange in morning trading.

 

 

Related Articles Read More >

This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE